Format

Send to

Choose Destination
CMAJ. 2019 Jul 22;191(29):E811-E815. doi: 10.1503/cmaj.181721.

Should national pharmacare apply a value-based insurance design?

Author information

1
Kaiser Permanente Washington Health Research Institute (Yeung), Seattle, Wash.; School of Population and Public Health (Morgan), The University of British Columbia, Vancouver, BC Kai.Yeung@kp.org.
2
Kaiser Permanente Washington Health Research Institute (Yeung), Seattle, Wash.; School of Population and Public Health (Morgan), The University of British Columbia, Vancouver, BC.
PMID:
31332049
PMCID:
PMC6645923
[Available on 2020-07-22]
DOI:
10.1503/cmaj.181721

Conflict of interest statement

Competing interests: Kai Yeung is a research scientist at Kaiser Permanente Washington Health Research Institute, a nonproprietary, public-interest research centre in Washington State. Steven Morgan has received funding from the Government of Canada for research in support of the Advisory Council on the Implementation of National Pharmacare.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center